-
-
Ključne reči:
-
Sažetak
-
Reference
1. Wat JM, Baczyk D, Kingdom JC. The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia. Biology of Reproduction, 2020;102(5):1102-1110.
2. Ou L, Liu H, Shi X, Peng C, Zou Y, Jia J, Li H, Zhu Z, Wang Y, Su B, Lai Y, Chen M, Zhu W, Feng Z, Zhang G, Yao M. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. Journal of Ethnopharmacology, 2024, 320:117428(1-14).
3. Nnate DA, Mabhala M, Massey A. Effectiveness of nitric oxide agents in preventing the early onset of pre-eclampsia and possible modification of metabolic factors in high-risk pregnancies: A systematic review protocol. JBI Evidence Synthesis, 2020;18(12):2658-2665.
4. Chen L, Wu M, Luo X. Correlation between mmp-9 and ngal in serum of pregnant women with preeclampsia and oxidative stress injury and apoptosis of placenta. Acta Medica Mediterranea, 2021;37(1):673-678.
5. Hong L, Xing B, Xing Y, Wang X, Liu Y, Li N, Shi D. Association between plasma ST2 and severity, maternal complications, fetal outcome in patients with preeclampsia. Journal of Biological Regulators and Homeostatic Agents, 2023;37(1):161-167.
6. Liu H, Tang T. A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. American Journal of Translational Research, 2023;15(3):2140-2155.
7. Aleidan FA, Aljarba GA, Aldakhil AA, Allehyani BI, Yahia MA, Alghtani NE, Badri M, Alaklabi AA, Alsuhaibani A, Crowther MA. A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin. International Journal of Hematology, 2020;112:1-7.
8. Wang X, Zeng W, Yang L, Chang T, Zeng J. Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients. Cancer Genetics, 2023;274-275:41-50.
9. Shaaban OM, Abbas AM, Zahran KM, Fathalla MM, Anan MA, Salman SA. Low-molecular-weight heparin for the treatment of unexplained recurrent miscarriage With negative antiphospholipid antibodies: a randomized controlled trial. Clinical and Applied Thrombosis/hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 2016;23(6):567-572
10. Wang T, Yao Y, Xu T, Wang W, Zhou Y, He J, Jiang R. Application of low molecular weight heparins in umbilical artery thrombosis: a case series and review of the literature. Medicine, 2023;102(15):38-41.
11. Sun B, Li L, Chen X, Sun Y. Effect of low-molecular-weight heparin in women undergoing frozen-thawed embryo transfer cycles: a retrospective cohort study. BMC Pregnancy and Childbirth, 2023;23(1):1-10.
12. Tong Y, Shao X, Sun Q, Wang Z. Effects of magnesium sulphuricum combined with low molecular weight heparin sodium on the blood pressure, DD and hs-CRP levels in patients with severe preeclampsia. International Journal of Clinical and Experimental Medicine, 2020;13(9):6803-6809.
13. Bistervels IM, Wiegers HM, Áinle FN, Bleker SM, Chauleur C, Donnelly J, Jacobsen AF, Rodger MA, DeSancho MT, Verhamme P, Hansen AT, Shmakov RG, Ganzevoort W, Buchmüller A, Middeldorp S, Highlow Investigators. Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study. Journal of Thrombosis and Haemostasis, 2023;21(1):57-67.
14. ÖZER Gülizar, YILDIZ Ç, ÖZER H, Çetin A. The effect of low molecular weight heparins on placentation: a rat model study. Cumhuriyet Science Journal, 2022;43(4):564-568.
15. Jiang F, Hu X, Jiang K, Pi H, He Q, Chen X. The role of low molecular weight heparin on recurrent pregnancy loss: a systematic review and meta-analysis. Taiwanese Journal of Obstetrics and Gynecology, 2021;60(1):1-8.
16. Beta J, Khan N, Khalil A, Fiolna M, Ramadan G, Akolekar R. Maternal and neonatal complications of fetal macrosomia: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology, 2019,54(3):308-318.
17. Cao J. Expression and significance of TOLL2, TARC and MDC in placenta tissue of pregnant patients infected with syphilis. Cellular and Molecular Biology, 2022;68(2):54-59.
18. Lee CL, Veerbeek JH, Rana TK, van Rijn BB, Burton GJ, Yung HW. Role of endoplasmic reticulum stress in proinflammatory cytokine-mediated inhibition of trophoblast invasion in placenta-related complications of pregnancy. The American Journal of Pathology, 2019;189(2):467-478.
19. Broekhuizen M, de Vries R, Smits MA, Dik WA, Schoenmakers S, Koch BC, Merkus D, Reiss IK, Danser AJ, Simons SH. Pentoxifylline as a therapeutic option for pre‐eclampsia: a study on its placental effects. British Journal of Pharmacology, 2022;179(22):5074-5088.
20. Villani M, Ageno W, Grandone E, Dentali F. The prevention and treatment of venous thromboembolism in pregnancy. Expert Review of Cardiovascular Therapy, 2017;15(5):397-402.
21. Yin M, Qin X. Meta-analysis of the efficacy of low molecular weight heparin and aspirin in the treatment of thrombosis during pregnancy and effects on coagulation function. Discovery Medicine, 2023;35(175):104-115.
2. Ou L, Liu H, Shi X, Peng C, Zou Y, Jia J, Li H, Zhu Z, Wang Y, Su B, Lai Y, Chen M, Zhu W, Feng Z, Zhang G, Yao M. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. Journal of Ethnopharmacology, 2024, 320:117428(1-14).
3. Nnate DA, Mabhala M, Massey A. Effectiveness of nitric oxide agents in preventing the early onset of pre-eclampsia and possible modification of metabolic factors in high-risk pregnancies: A systematic review protocol. JBI Evidence Synthesis, 2020;18(12):2658-2665.
4. Chen L, Wu M, Luo X. Correlation between mmp-9 and ngal in serum of pregnant women with preeclampsia and oxidative stress injury and apoptosis of placenta. Acta Medica Mediterranea, 2021;37(1):673-678.
5. Hong L, Xing B, Xing Y, Wang X, Liu Y, Li N, Shi D. Association between plasma ST2 and severity, maternal complications, fetal outcome in patients with preeclampsia. Journal of Biological Regulators and Homeostatic Agents, 2023;37(1):161-167.
6. Liu H, Tang T. A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. American Journal of Translational Research, 2023;15(3):2140-2155.
7. Aleidan FA, Aljarba GA, Aldakhil AA, Allehyani BI, Yahia MA, Alghtani NE, Badri M, Alaklabi AA, Alsuhaibani A, Crowther MA. A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin. International Journal of Hematology, 2020;112:1-7.
8. Wang X, Zeng W, Yang L, Chang T, Zeng J. Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients. Cancer Genetics, 2023;274-275:41-50.
9. Shaaban OM, Abbas AM, Zahran KM, Fathalla MM, Anan MA, Salman SA. Low-molecular-weight heparin for the treatment of unexplained recurrent miscarriage With negative antiphospholipid antibodies: a randomized controlled trial. Clinical and Applied Thrombosis/hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 2016;23(6):567-572
10. Wang T, Yao Y, Xu T, Wang W, Zhou Y, He J, Jiang R. Application of low molecular weight heparins in umbilical artery thrombosis: a case series and review of the literature. Medicine, 2023;102(15):38-41.
11. Sun B, Li L, Chen X, Sun Y. Effect of low-molecular-weight heparin in women undergoing frozen-thawed embryo transfer cycles: a retrospective cohort study. BMC Pregnancy and Childbirth, 2023;23(1):1-10.
12. Tong Y, Shao X, Sun Q, Wang Z. Effects of magnesium sulphuricum combined with low molecular weight heparin sodium on the blood pressure, DD and hs-CRP levels in patients with severe preeclampsia. International Journal of Clinical and Experimental Medicine, 2020;13(9):6803-6809.
13. Bistervels IM, Wiegers HM, Áinle FN, Bleker SM, Chauleur C, Donnelly J, Jacobsen AF, Rodger MA, DeSancho MT, Verhamme P, Hansen AT, Shmakov RG, Ganzevoort W, Buchmüller A, Middeldorp S, Highlow Investigators. Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study. Journal of Thrombosis and Haemostasis, 2023;21(1):57-67.
14. ÖZER Gülizar, YILDIZ Ç, ÖZER H, Çetin A. The effect of low molecular weight heparins on placentation: a rat model study. Cumhuriyet Science Journal, 2022;43(4):564-568.
15. Jiang F, Hu X, Jiang K, Pi H, He Q, Chen X. The role of low molecular weight heparin on recurrent pregnancy loss: a systematic review and meta-analysis. Taiwanese Journal of Obstetrics and Gynecology, 2021;60(1):1-8.
16. Beta J, Khan N, Khalil A, Fiolna M, Ramadan G, Akolekar R. Maternal and neonatal complications of fetal macrosomia: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology, 2019,54(3):308-318.
17. Cao J. Expression and significance of TOLL2, TARC and MDC in placenta tissue of pregnant patients infected with syphilis. Cellular and Molecular Biology, 2022;68(2):54-59.
18. Lee CL, Veerbeek JH, Rana TK, van Rijn BB, Burton GJ, Yung HW. Role of endoplasmic reticulum stress in proinflammatory cytokine-mediated inhibition of trophoblast invasion in placenta-related complications of pregnancy. The American Journal of Pathology, 2019;189(2):467-478.
19. Broekhuizen M, de Vries R, Smits MA, Dik WA, Schoenmakers S, Koch BC, Merkus D, Reiss IK, Danser AJ, Simons SH. Pentoxifylline as a therapeutic option for pre‐eclampsia: a study on its placental effects. British Journal of Pharmacology, 2022;179(22):5074-5088.
20. Villani M, Ageno W, Grandone E, Dentali F. The prevention and treatment of venous thromboembolism in pregnancy. Expert Review of Cardiovascular Therapy, 2017;15(5):397-402.
21. Yin M, Qin X. Meta-analysis of the efficacy of low molecular weight heparin and aspirin in the treatment of thrombosis during pregnancy and effects on coagulation function. Discovery Medicine, 2023;35(175):104-115.
Objavljeno
2025/04/14
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Liucheng Pei
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.